Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioMedWire Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1275894206469267456.png) BioMedWire [@BioMedWire](/creator/twitter/BioMedWire) on x 1297 followers
Created: 2025-07-24 18:00:18 UTC

$AZN new immune disorder treatment shows success in late-stage trials, offering hope for patients with rare conditions. A major step forward in targeted therapies:

#AstraZeneca #ImmuneHealth #RareDiseases #BiotechNews #ClinicalTrials

![](https://pbs.twimg.com/card_img/1948339676248449024/PiJLq1tD?format=jpg&name=800x419)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948443135115182458/c:line.svg)

**Related Topics**
[azn astrazeneca](/topic/azn-astrazeneca)
[manat](/topic/manat)
[$azn](/topic/$azn)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/BioMedWire/status/1948443135115182458)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BioMedWire Avatar BioMedWire @BioMedWire on x 1297 followers Created: 2025-07-24 18:00:18 UTC

$AZN new immune disorder treatment shows success in late-stage trials, offering hope for patients with rare conditions. A major step forward in targeted therapies:

#AstraZeneca #ImmuneHealth #RareDiseases #BiotechNews #ClinicalTrials

XX engagements

Engagements Line Chart

Related Topics azn astrazeneca manat $azn stocks healthcare

Post Link

post/tweet::1948443135115182458
/post/tweet::1948443135115182458